Suven Life Sciences Completes Preferential Allotment, Appoints Director, and Informs Singapore Subsidiary Incorporation

Suven Life Sciences Completes Preferential Allotment, Appoints Director, and Informs Singapore Subsidiary Incorporation​

Suven Life Sciences Limited announced that its Board of Directors approved the preferential allotment of equity shares following the conversion of fully paid warrants. The company also greenlit the re-appointment of Dr. Vajja Sambasiva Rao as a Non-Executive Independent Director and confirmed the incorporation of a wholly owned subsidiary in Singapore.

Equity Allotment Details​

The Company converted 185,70,133 fully paid warrants and consequently issued and allotted 185,70,133 equity shares at an issue price of Rs. 134 per share to various Non-Promoter Persons and Entities. The aggregate consideration received for these shares amounted to Rs. 248,83,97,822.

The allotment was made across 17 entities, including TEJAS TRIVEDI, KETAN CHHOTALAL SHETH, and ITI HOLDINGS AND INVESTMENT PRIVATE LIMITED. Other allottees included ARUN NAHAR, JAGDISH NMASTER, NILESH KISHORE SHAH, and ORACULAR ADVISORY PRIVATE LIMITED. The allotment list details the shares allotted to each entity, with NIMESH ARVIND DOSHI receiving 11,94,100 shares.

Prior to this transaction, the Company's subscribed and paid up equity share capital stood at Rs. 26,39,92,553, corresponding to 263,99,2553 equity shares. Post-issue, the total subscribed and paid up capital increased to Rs. 28,25,62,686, comprising 282,56,2686 fully paid up equity shares of Rs. 1 each.

Corporate Governance and Director Reappointment​

The Board of Directors approved the re-appointment of Dr. Vajja Sambasiva Rao (DIN: 09233939) as a Non-Executive Independent Director for a second term. This appointment is effective from January 21, 2027, covering a tenure of five years, subject to approval by the Members at the ensuing Annual General Meeting.

Dr. Vajja Sambasiva Rao possesses extensive experience in chemistry and governance. He holds Master of Science and Ph.D Chemistry degrees from BITS Pilani and is an alumnus of both BITS Pilani and the University of Bielefeld, Germany. His professional background includes serving as the Vice Chancellor of SRM University-AP until September 9, 2022, and later advising the President and Pro-Chancellor of SRM University AP until October 2025. He has also served as Advisor to BITS Pilani Amaravati Campus since November 1, 2025, and previously held roles including President of NIIT University and Acting Vice-Chancellor at BITS, Pilani.

Incorporation of Singapore Subsidiary​

The Board Meeting reviewed the incorporation of a Wholly Owned Subsidiary (WOS) in Singapore. The entity to be incorporated is Suven Neurosciences Pte. Ltd., with Suven Life Sciences Limited as the holding company.

This new subsidiary will operate within the Bio-Pharmaceutical and clinical development industry, focusing on the acquisition, development, and commercialization of novel therapeutics for neurological disorders. The incorporation involves a total investment amount of USD 100.00Mn at a price of SGD 1.00 per share, with the listed entity controlling 100% of the shares through cash subscription.

SUVEN Stock Price Movement​

As of 12:54 PM, shares of Suven Life Sciences Limited are rising to ₹321.75, climbing by ₹2.40 or 0.75%. The equity trades with a volume of 482,895 shares as the company continues to post gains in the live market.